Previous 1 2 3 4
27.01.2009 - DJ HUGIN NEWS/JPT Launches "PepTrack(TM) - Peptide Library Technologies" for T-cell Assays in Vaccine ...
Berlin, Germany, January 27, 2009 - JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of Jerini AG (FSE:JI4), announced today the launch of its new product line: PepTrack(TM). Designed for peptides in T-cell assays (ELISPOT, CFC, ICS and others), this approach represents the most efficient technique for producing large numbers of peptides simultaneously. (Tue, 27 Jan 2009 08:54:46 GMT)
Research and Markets: Extremely Essential Detailed Cancer Market Outlook to 2013 Report: Competitive Landscape, ...
DUBLIN, Ireland----Research and Markets has announced the addition of the The Cancer Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth Opportunities report to their offering. (Tue, 27 Jan 2009 09:36:00 GMT)
Illumina Launches Suite of Next-Generation Sequencing Kits
SAN DIEGO----Illumina today announced the release of new sequencing chemistry kits and complementary software for its Genome Analyzer system. These new kits and software enable researchers to generate 40% more reads per run and extend read length to greater than 75 base pairs . (Tue, 27 Jan 2009 11:00:00 GMT)
A Genome-Wide Study Of Transcription In Yeast Redefines The Concept Of Promoters
Genes that contain instructions for making proteins make up less than 2% of the human genome. Yet, for unknown reasons, most of our genome is transcribed into RNA. The same is true for many other organisms that are easier to study than humans. (Tue, 27 Jan 2009 11:20:20 GMT)
Illumina Launches Suite of Next-Generation Sequencing Kits
Illumina (NASDAQ:ILMN) today announced the release of new sequencing chemistry kits and complementary software for its Genome Analyzer system. These new kits and software enable researchers to generate 40% more reads per run and extend read length to greater than 75 base pairs (bp). Also launched is the new Mate Pair Library Preparation Kit, which provides support for generating longer insert ... (Tue, 27 Jan 2009 11:27:23 GMT)
Researchers pinpoint gene that helps tumors spread
A gene that makes breast cancer tumors more likely to resist chemotherapy and to spread to other organs has been identified by a team of New Jersey researchers. (Tue, 27 Jan 2009 11:55:32 GMT)
University of Glasgow Becomes a Member of GeneGo s MetaMiner Stem Cell Partnership Program
GeneGo, Inc., the leading systems biology tools company, announced today that Professor Nicol Keith of the University of Glasgow will join the MetaMiner Stem Cell Partnership Program. (Tue, 27 Jan 2009 12:00:00 GMT)
Roche Applied Science Makes Exome Sequencing a Reality, a Giant Step Towards Personalized Medicine
MADISON, Wis. & BRANFORD, Conn.----A key milestone for personalized medicine has been achieved by two Roche Applied Science companies, Roche NimbleGen and 454 Life Sciences, in developing revolutionary technologies to resequence all human exons from individual genomes. (Tue, 27 Jan 2009 13:00:00 GMT)
Roche Applied Science Makes Exome Sequencing a Reality, a Giant Step Towards Personalized Medicine
A key milestone for personalized medicine has been achieved by two Roche Applied Science companies, Roche NimbleGen and 454 Life Sciences, in developing revolutionary technologies to resequence all human exons from individual genomes. Roche NimbleGen has launched Sequence Capture 2.1M Human Exome microarrays, built on the HD2 platform, which allows researchers to capture all exons in the genome ... (Tue, 27 Jan 2009 13:41:42 GMT)
Aethlon Medical Appoints Dr. Prashant Mehta as Director of Business Development
Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has appointed Prashant Mehta, Ph.D. to the newly created Director of Business Development position. Dr. Mehta has extensive biotechnology and financial industry experience, and since 2006 has been Managing Director of Gemini Strategies LLC, a manager of small-cap institutional funds with investments in the life science and medical device ... (Tue, 27 Jan 2009 14:57:33 GMT)
Ceetron and Fraunhofer SCAI sign contract
Sankt Augustin. Ceetron and the Fraunhofer Institute for Algorithms and Scientific Computing SCAI today announce the signature of a software agreement between the organizations. (Tue, 27 Jan 2009 14:59:34 GMT)
New insights into a leading poultry disease and its risks to human health
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC). APEC is part of a large, diverse group of microbes called extra-intestinal pathogenic E. coli (ExPEC). They cause a number of complex ... (Tue, 27 Jan 2009 15:01:07 GMT)
New insights into a leading poultry disease and its risks to human health
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC). (Tue, 27 Jan 2009 15:13:05 GMT)
New Insights Into A Leading Poultry Disease And Its Risks To Human Health
Scientists are developing a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC). They has now analyzed the critical genetic element of APEC that contains several genes responsible for triggering its harmful effects. They have also shown that human and avian E. coli can carry the same disease-causing elements, which may increase the human risk of infection from ... (Tue, 27 Jan 2009 15:19:30 GMT)
We Thought that Was a Fair Trade, But Maybe Not
Here's an (unintentionally) entertaining article from Forbes about how compute-intensive genomics is . "People want to live longer, but the cost may be enormous and create fallout in places you never expected," the article reports. (Tue, 27 Jan 2009 15:53:19 GMT)
New Deerac Q Rapidly Prepares 384-Well Genomic Assays
SUNNYVALE, Calif.----Labcyte Inc. announced today the introduction of the new Deerac Q which integrates two distinct and necessary liquid handling systems into a single platform for preparing low volume genomic assays. (Tue, 27 Jan 2009 16:00:00 GMT)
New Deerac™ Q Rapidly Prepares 384-Well Genomic Assays
Labcyte Inc. announced today the introduction of the new Deerac Q which integrates two distinct and necessary liquid handling systems into a single platform for preparing low volume genomic assays. By combining the proven Deerac magnetic feedback control (MFC) dispensing technology with a 96-channel pipettor with disposable tips, the Deerac Q saves time, reduces process risks, and eliminates the ... (Tue, 27 Jan 2009 16:26:42 GMT)
Now Shipping, New Infobionics Knowledge Server™ Liberates Data Throughout the Enterprise
Infobionics is now shipping the revolutionary Infobionics Knowledge Server™ that finally delivers on the promise of business intelligence by liberating data throughout the enterprise from today’s rigid database structures. (Tue, 27 Jan 2009 16:28:54 GMT)
Labcyte Launches Walk-Away, Out-of-the-Box Solution
SUNNYVALE, Calif.----Labcyte Inc. announces the revolutionary Intellectual Scheduler for its POD™ 810 system, which assembles assay-ready “plates-on-demand” for optimizing drug discovery. (Tue, 27 Jan 2009 17:00:00 GMT)
Labcyte Launches Walk-Away, Out-of-the-Box Solution
Labcyte Inc. announces the revolutionary Intellectual Scheduler for its POD™ 810 system, which assembles assay-ready “plates-on-demand” for optimizing drug discovery. Unlike traditional sequential schedulers, the Labcyte ® Intellectual Scheduler is event-based, with built-in intelligence to automatically adjust workflow. The Intellectual Scheduler was developed to maximize productivity and to ... (Tue, 27 Jan 2009 17:27:09 GMT)
Mixing Genomics And Geography Yields Insights Into Life And Environment
Marrying genomics and geography on a grand scale, researchers have detected often-subtle molecular changes that occur within micro-organisms living in a host of different marine environments. (Tue, 27 Jan 2009 17:37:21 GMT)
Novel Diabetes Drug Discovery Has Potential to Reverse Disease
A study released today in Endocrine Practice , the leading peer-reviewed journal for practicing endocrinologists in the US and (Tue, 27 Jan 2009 18:00:00 GMT)
U.S. Genomics renews Woburn lease
U.S. Genomics renewed its lease with landlord Cummings Properties LLC for nearly 40,000 square feet of office and lab space in Woburn, Mass. (Tue, 27 Jan 2009 19:22:26 GMT)
CLC Bio Bridges Digital and Analogue Gene Expression with the New Version of CLC Genomics Workbench
AARHUS, Denmark----CLC bio has just released version 3.0 of their highly popular solution for analyzing and visualizing Next Generation Sequencing data, CLC Genomics Workbench. The new version is crammed with new and powerful features, like digital gene expression, expression analysis of micro arrays and RNA-seq data – and an overhauled long reads assembler which is up to 15 times faster than ... (Tue, 27 Jan 2009 21:00:00 GMT)
SQI Diagnostics Raises $1.3M in Second Stock Placement to Support Dx Pipeline, Sales Effort
SQI Diagnostics, a Toronto-based developer of microarray-based tests, last week announced that it had closed a CDN$1.6 million ($1.3 million) second tranche of a non-brokered private placement of stock, bringing to CDN$4.6 million the total proceeds from the placement. (Tue, 27 Jan 2009 21:08:08 GMT)
IP Roundup
Tigenix of Leuven, Belgium, has received US Patent No. 7,482,114, “ In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation.” (Tue, 27 Jan 2009 21:08:18 GMT)
CLC Bio Bridges Digital and Analogue Gene Expression with the New Version of CLC Genomics Workbench
CLC bio has just released version 3.0 of their highly popular solution for analyzing and visualizing Next Generation Sequencing data, CLC Genomics Workbench. The new version is crammed with new and powerful features, like digital gene expression, expression analysis of micro arrays and RNA-seq data – and an overhauled long reads assembler which is up to 15 times faster than the previous version! (Tue, 27 Jan 2009 21:12:07 GMT)
New Products
According to the company, the new chemistry kits and software increase the number of reads per run by 40 percent and extend the read length to more than 75 base pairs. (Tue, 27 Jan 2009 22:08:29 GMT)
Indian Bioinformatics Company Questar to Make Equity Investment, Partner with AlphaGene
NEW YORK, June 18 - AlphaGene has partnered with Indian bioinformatics company Questar to mine its protein database, the companies said Monday. In the collaboration, Questar, of Ameerpet, Hyderabad will make an equity investment in Woburn, Mass.-based AlphaGene. (Tue, 27 Jan 2009 22:53:30 GMT)
Affymetrix to Host Conference Call on January 28, 2009 to Announce Fourth Quarter and Fiscal 2008 Results
Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will release results for the fourth quarter and fiscal year 2008 after close of the stock market on Wednesday, January 28, 2009. (Tue, 27 Jan 2009 22:56:32 GMT)
Boreal Genomics Launches DNA-Extraction Tech as Sage Sciences Develops DNA-Prep Method
Two startup companies are entering the DNA sample preparation market, and are working on applications for constructing second-generation sequencing libraries. (Tue, 27 Jan 2009 23:08:19 GMT)
CLC Genomics Workbench 3 improves assembler speed
CLC bio has released Genomics Workbench 3, the latest version of its analysis and visualization software for Next Generation Sequencing (NGS) data. The application uses an SIMD-accelerated assembly algorithm to analyze NGS data, with a 15-fold speed improvement compared to the previous version, the company claims. Once analyzed, the visualization tools allow users to spot genetic changes such as ... (Wed, 28 Jan 2009 02:31:24 GMT)
23andMe and mondoBIOTECH Partner to Advance Research of Rare Diseases
DAVOS, Switzerland, January 28 /PRNewswire/ -- 23andMe, Inc., an industry leader in personal genetics, and mondoBIOTECH AG, a Swiss research company dedicated to the development of treatments for rare diseases, today announced at the World Economic Forum in Davos, Switzerland, that they are collaborating to advance research of rare diseases. (Wed, 28 Jan 2009 08:04:20 GMT)
Leuchemix Provides Update On Cancer Trial
MUKILTEO, Wash., Jan. 28, 2009 -- CombiMatrix Corporation announced today that Leuchemix provided additional information regarding the initial clinical trial of its novel anticancer drug LC-1. (Wed, 28 Jan 2009 11:00:00 GMT)
Novel Diabetes Drug Discovery Has Potential To Reverse Disease
A study released in Endocrine Practice (2008;14:1075), the leading peer-reviewed journal for practicing endocrinologists in the US and 65 countries, reports a ground breaking discovery with the potential to reverse type 1 and 2 diabetes. Scientists at CureDM, Inc. (Wed, 28 Jan 2009 12:20:19 GMT)
CLC Bio Bridges Digital And Analogue Gene Expression With The New Version Of CLC Genomics Workbench
CLC bio has just released version 3.0 of their highly popular solution for analyzing and visualizing Next Generation Sequencing data, CLC Genomics Workbench. (Wed, 28 Jan 2009 13:19:09 GMT)
Dynamic Media Holdings, Inc. Announces Research Partnership Between Evermedia Biometrics and the University of ...
Dynamic Media Holdings, Inc. is pleased to announce that Evermedia Biometrics Corporation, a wholly owned subsidiary of Dynamic Media Holdings, Inc., has signed a Memorandum of Understanding with The Peter Kiewit Institute, one of the nation's leading institutes for information science, technology and engineering. (Wed, 28 Jan 2009 13:30:00 GMT)
Genomatix joins Illumina-Connect program
( Genomatix Software GmbH ) Genomatix Software announced today that is has joined the Illumina-Connect program, linking them to the ongoing Illumina program and working with them to develop new tools and applications for Illumina-generated data. (Wed, 28 Jan 2009 15:14:21 GMT)
Mondobiotech, 23andMe Team on Rare Disease Research
NEW YORK (GenomeWeb News) — 23andMe and Swiss company Mondobiotech will collaborate to offer researchers information about certain rare genetic diseases, the California consumer genomics firm said today. (Wed, 28 Jan 2009 15:53:18 GMT)
Exercise Does Not Appear To Raise Damage To Joints
There is no good evidence supporting a harmful effect of exercise on joints in the setting of normal joints and regular exercise, according to a review of studies published in this month's issue of the Journal of Anatomy. Exercise is an extremely popular leisure-time activity in many countries throughout the Western world and has for many become part of the modern lifestyle. (Wed, 28 Jan 2009 16:21:54 GMT)
It'll Leave You More Time to Write Grants
Michael Barton at Bioinformatics Zen hands out some tips on when to reuse and when to write new code. Libraries already exist -- for instance, BioPerl -- that house functions for many common tasks, such as reading Fasta files or parsing Blast results. (Wed, 28 Jan 2009 16:53:16 GMT)
Neuroscience: Making connections
By turning neurons technicolour, Jeff Lichtman exposed the brain's wiring. Jonah Lehrer meets the 'unapologetic cell biologist' with ambitions to map every connection in the human brain. (Wed, 28 Jan 2009 18:09:40 GMT)
Navigenics launches online portal for doctors
Personal genomics testing company Navigenics Inc. said Wednesday it launched a physician-focused online portal for doctors to access the genomic information of consenting patients. (Wed, 28 Jan 2009 19:36:10 GMT)
23andMe in rare-disease research collaboration
23andMe Inc. and mondoBiotech AG said Wednesday they are collaborating to advance research of rare diseases. (DNA) (GOOG) (Wed, 28 Jan 2009 20:03:09 GMT)
Affymetrix Reports Fourth Quarter and Fiscal Year 2008 Results
SANTA CLARA, Calif.----Affymetrix Inc., today reported its operating results for the fourth quarter and fiscal year ended December 31, 2008. Total revenue for the fourth quarter was $78.6 million, as compared to total revenue of $107.6 million in the fourth quarter of 2007. (Wed, 28 Jan 2009 21:00:00 GMT)
Stem cells used to reverse paralysis in animals
( Wiley-Blackwell ) A new study has found that transplantation of stem cells from the lining of the spinal cord, called ependymal stem cells, reverses paralysis associated with spinal cord injuries in laboratory tests. The findings show that the population of these cells after spinal cord injury was many times greater than comparable cells from healthy animal subjects. (Wed, 28 Jan 2009 21:03:48 GMT)
Affymetrix Reports Fourth Quarter and Fiscal Year 2008 Results
Affymetrix Inc., (NASDAQ:AFFX) today reported its operating results for the fourth quarter and fiscal year ended December 31, 2008. Total revenue for the fourth quarter was $78.6 million, as compared to total revenue of $107.6 million in the fourth quarter of 2007. For the full year, total revenue was $410.2 million as compared to $371.3 million for 2007. (Wed, 28 Jan 2009 21:27:54 GMT)
Need-to-know news and views for UB faculty and staff
To tackle an increasing global infectious-disease burden and rising rates of drug-resistant infections, UB philosophers are working with medical researchers to develop the first-ever infectious disease ontology. (Wed, 28 Jan 2009 21:35:40 GMT)
Six teams receive IRDF awards
Six research teams have been awarded seed grants in the latest round of funding from the UB 2020 Interdisciplinary Research Development Fund (IRDF). (Wed, 28 Jan 2009 21:36:23 GMT)
TCAG Taps GenoLogics for Lab and Data Management
NEW YORK (GenomeWeb News) — The Centre for Applied Genomics at The Hospital for Sick Children is using GenoLogics' lab and data management system at the center's multiple facilities, the company said yesterday. (Wed, 28 Jan 2009 21:38:30 GMT)
CLINICAL IMPLICATIONS OF BASIC RESEARCH: Getting to the Heart of Proteomics
Proteomic analysis of heart tissue in animal models of myocardial infarction shows that phosphorylation of an aldehyde dehydrogenase protects against ischemic insults. (Wed, 28 Jan 2009 23:04:34 GMT)
CLC bio releases version 3.0 of CLC Genomics Workbench
CLC bio has just released version 3.0 of their highly popular solution for analyzing and visualizing next generation sequencing data, CLC Genomics Workbench. (Thu, 29 Jan 2009 07:34:02 GMT)
Genomics offer solution to dairy inbreeding Farmers Weekly
Genomics – considered the biggest advance in cattle breeding since frozen semen – is likely to be used most widely to avoid inbreeding in dairy cow populations. (Thu, 29 Jan 2009 09:34:47 GMT)
Builder gives Burnham $10 million gift
Though he's made millions as a builder, Conrad Prebys said he never fulfilled his dream of erecting an expansive bridge or high-rise that would be synonymous with his name. But a $10 million donation to the nonprofit Burnham Institute for Medical Research means his name will now be on the institute's Center for Chemical Genomics. (Thu, 29 Jan 2009 10:04:23 GMT)
New Deerac™ Q Rapidly Prepares 384-Well Genomic Assays
Labcyte Inc. announced the introduction of the new Deerac Q which integrates two distinct and necessary liquid handling systems into a single platform for preparing low volume genomic assays. (Thu, 29 Jan 2009 11:19:40 GMT)
Roche Applied Science Makes Exome Sequencing A Reality, A Giant Step Towards Personalized Medicine
A key milestone for personalized medicine has been achieved by two Roche Applied Science companies, Roche NimbleGen and 454 Life Sciences, in developing revolutionary technologies to resequence all human exons from individual genomes. Roche NimbleGen has launched Sequence Capture 2. (Thu, 29 Jan 2009 11:20:40 GMT)
UNT Health Science Center Researchers Discover Eating Less May Not Increase Life Expectancy
Dr. Michael Forster of the UNT Health Science Center and Dr. Raj Sohal of the University of Southern California's School of Pharmacy have discovered that eating less may not be a key to living longer. Their study and others by Health Science Center researchers were recently published in several scientific journals and articles. (Thu, 29 Jan 2009 11:22:57 GMT)
Stem Cells Used To Reverse Paralysis In Animals
A new study has found that transplantation of stem cells from the lining of the spinal cord, called ependymal stem cells, reverses paralysis associated with spinal cord injuries in laboratory tests. The findings show that the population of these cells after spinal cord injury was many times greater than comparable cells from healthy animal subjects. (Thu, 29 Jan 2009 12:21:25 GMT)
Bacteria-based biofuel
US researchers have genetically modified Escherichia coli to produce unusually long-chain alcohols that could be used as fuel. (Thu, 29 Jan 2009 13:35:25 GMT)
Genomics offer solution to dairy inbreeding Farmers Weekly
Genomics – considered the biggest advance in cattle breeding since frozen semen – is likely to be used most widely to avoid inbreeding in dairy cow populations. (Thu, 29 Jan 2009 14:34:43 GMT)
TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study new cancer drug
( The Translational Genomics Research Institute ) TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic are testing a new drug that may offer broad potential to treat solid tumors. (Thu, 29 Jan 2009 14:47:04 GMT)
Research and Markets: Molecular and Biochemical Toxicology is an Essential Resource for Graduate Students, Academic ...
DUBLIN, Ireland----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Molecular and Biochemical Toxicology, 4th Edition" to their offering. (Thu, 29 Jan 2009 15:00:00 GMT)
Inova Health System partners with George Mason University
Inova Health System is starting a new $1 million fund at George Mason University to flow toward joint life sciences research between the two frequent partners. (Thu, 29 Jan 2009 16:01:44 GMT)
Genome Canada head questions lack of funds in budget
The head of the not-for-profit group responsible for funding large-scale science and genetics projects is perplexed after the foundation was shut out of funding in the federal budget. (Thu, 29 Jan 2009 16:40:26 GMT)
Genome Canada head questions lack of funds in budget
The head of the not-for-profit group responsible for funding large-scale science and genetics projects is perplexed after the foundation was shut out of funding in the federal budget. (Thu, 29 Jan 2009 17:36:33 GMT)
Critics question lack of new funding for Genome Canada
The head of the not-for-profit group responsible for funding large-scale science and genetics projects is perplexed after the foundation was shut out of funding in the federal budget. (Thu, 29 Jan 2009 18:34:08 GMT)
Recent Patents of Interest in Proteomics
US Patent 7,482,581. Fourier transform mass spectrometer and method for generating a mass spectrum therefrom . Inventors: Oliver Lange; Andreas Wieghaus. (Thu, 29 Jan 2009 18:38:27 GMT)
Q&A: Building a Library of Mitochondrial Proteins for Disease Studies
While mitochondria are essential for cellular life, death, and differentiation, little is known about the proteins that make up the organelles. (Thu, 29 Jan 2009 18:53:09 GMT)
Waters’ Instruments Sales Slide 5-Percent in Q4 as Sales Slip 4 Percent
Waters this week reported a 5 percent decline in instrument sales in the final quarter of 2008 and forecast a deeper slide in that part of its business for the new year. (Thu, 29 Jan 2009 19:08:09 GMT)
Genome Canada Nets Nil from '09 Federal Budget
NEW YORK (GenomeWeb News) — The Canadian government has granted no money in its budget for the coming year to fund Genome Canada, the biomedical and biotechnology-focused entity that supports science in the country, the non-profit organization's President, Martin Godbout, told GenomeWeb Daily News today. (Thu, 29 Jan 2009 20:38:09 GMT)
New insights into a avian pathogenic E. coli and its risks to human health
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC). (Thu, 29 Jan 2009 22:11:13 GMT)
PerkinElmer's Q4 Revenues Rise 3 Percent
NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its fourth-quarter revenues grew 3 percent, but the firm forecast that its 2009 revenues would be flat or down mid-single digits compared to 2008. (Thu, 29 Jan 2009 23:08:09 GMT)
Extra Credit: Hands-on activities make science fun
Students can now register for Science Alive, an annual conference for middle school students featuring hands-on activities that make science fun. Science Alive draws more than 300 middle school students from throughout the Bay Area. Science Alive helps young students connect with science, and also gain exposure to a college campus. Parent workshops are designed to help parents ... (Thu, 29 Jan 2009 23:28:32 GMT)
NT plans recruitment of freshmen for virus research
Things such as dissecting frogs, playing with microscopes and learning about photosynthesis usually come to mind when one hears the words "biology lab." However, biology professors at NT are now working diligently to modify this idea of biology labs to include "scientific discovery. (Fri, 30 Jan 2009 06:32:23 GMT)
Forbes Names Illumina America's Fastest-Growing Technology Company for Second Time
SAN DIEGO, Calif.----Illumina, Inc. today announced that Forbes named it to the top of the 2009 list of 25 Fastest-Growing Technology Companies in the United States. This is the second time in the past three years that Forbes has ranked Illumina #1 on its list of rapidly growing technology companies. (Fri, 30 Jan 2009 11:00:00 GMT)
Forbes Names Illumina America’s Fastest-Growing Technology Company for Second Time
Illumina, Inc. (NASDAQ:ILMN) today announced that Forbes named it to the top of the 2009 list of 25 Fastest-Growing Technology Companies in the United States. This is the second time in the past three years that Forbes has ranked Illumina #1 on its list of rapidly growing technology companies. Illumina develops, manufactures, and markets a full range of next-generation life science ... (Fri, 30 Jan 2009 11:26:59 GMT)
Gillibrand's trip to WNY is first as a U. S. senator
Sen. Kirsten E. Gillibrand will make her first visit to Western New York as a U. S. senator Saturday for closed-door meetings with top elected officials and a news conference. (Fri, 30 Jan 2009 12:08:48 GMT)
Complete Genomics to Release Its DNA Sequencing Data for the First Time at Advances in Genome Biology and Technology ...
Complete Genomics Inc., a newly launched, third-generation human genome sequencing company, today announced that it will release its sequencing data publically for the first time at the 10th annual Advances in Genome Biology and Technology meeting to be held in Marco Island, Fla., from Feb. 4-7. (Fri, 30 Jan 2009 13:00:00 GMT)
Genome of a heat and drought resistant cereal plant analyzed
( Helmholtz Zentrum München - German Research Center for Environmental Health ) As part of an international consortium of scientists, researchers at Helmholtz Zentrum Munchen are analyzing the genes of sorghum, the first plant of African origin whose genome has been sequenced. (Fri, 30 Jan 2009 14:30:38 GMT)
Burnham Chemical Genomics Center Lands $10M Gift
NEW YORK (GenomeWeb News) — The Burnham Institute for Medical Research has received a $10 million gift for its Center for Chemical Genomics from San Diego real estate developer Conrad Prebys, Burnham said yesterday. (Fri, 30 Jan 2009 15:23:08 GMT)
Company Profile for Massachusetts Life Science Center
----The Massachusetts Life Sciences Center is the hub for the state’s thriving life sciences community, which includes biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics. (Fri, 30 Jan 2009 15:40:00 GMT)
Preparing for climate change: Helmholtz Zentrum München researchers analyze the genome of a heat and drought resistant ...
The global climate is changing, and this change is already impacting food supply and security. People living in regions already affected by aridity need plants that can thrive / grow under dry conditions. (Fri, 30 Jan 2009 16:06:13 GMT)
Company Profile for Massachusetts Life Science Center
The Massachusetts Life Sciences Center (MLSC) is the hub for the state’s thriving life sciences community, which includes biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics. The Center is the steward of the state’s $1 billion investment to ensure that the life sciences continue to be a major economic engine for the Commonwealth of Massachusetts. The Center’s goals ... (Fri, 30 Jan 2009 16:06:31 GMT)
Cranes Software’s 9M FY09 Consolidated Revenues Up 26% to Rs. 3,523 Million
Cranes Software International Ltd. (Cranes): (Fri, 30 Jan 2009 17:11:31 GMT)
University Experts Available to Discuss Charles Darwin and Evolution
The University of California, San Diego is hosting a series of events this spring to celebrate the 200th anniversary of the birth of Charles Darwin and to reflect on how his ideas continue to influence science. The University also has a list of experts who can comment on Darwin and his rich legacy. (Fri, 30 Jan 2009 18:51:01 GMT)
People in the News
Stephane Perrey will serve as president of Qiagen KK, Qiagen's Tokyo subsidiary. He is taking over for Kazuo Tokushige , who retired on December 31. Perrey formerly worked at Third Wave/Hologic Japan and he held various positions in Japan's in vitro diagnostic industry. (Fri, 30 Jan 2009 19:54:12 GMT)
Forbes Names Luminex Corporation One of the 25 Fastest-Growing Technology Companies in America
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has been named one of the 25 Fastest-Growing Technology Companies in America by Forbes . (Fri, 30 Jan 2009 20:26:32 GMT)
Key to pre-eclampsia may be found in misfolded proteins in the urine
( Yale University ) Clues to the cause of pre-eclampsia, a common, but serious hypertension complication of pregnancy that has puzzled doctors and researchers for decades, point to proteins that misfold and aggregate, according to Yale School of Medicine researchers. (Fri, 30 Jan 2009 21:33:39 GMT)
New Products
MDS Analytical Technologies this week introduced six-channel and two-channel versions of the SpectraMax L , a new multiple photomultiplier-based platform for microplate luminometers. (Fri, 30 Jan 2009 22:23:19 GMT)
Downloads & Upgrades
CLC bio announced the release of version 3.0 of CLC Genomics Workbench, its software platform for analyzing and visualizing second-generation sequencing data. (Fri, 30 Jan 2009 22:38:16 GMT)
Key to pre-eclampsia may be found in misfolded proteins in the urine
Clues to the cause of preeclampsia, a common, but serious hypertension complication of pregnancy that has puzzled doctors and researchers for decades, point to proteins that misfold and aggregate, according to Yale School of Medicine researchers. (Fri, 30 Jan 2009 22:58:41 GMT)
Jim Watson’s Genome in an E-Mail? UC Irvine Team Develops Method to Compress Genomic Data
Scientists at the University of California Irvine have developed a new method to compress genomic data and have demonstrated in a recent paper that the approach can convert a human genome into an e-mailable attachment. (Fri, 30 Jan 2009 23:08:09 GMT)
Q&A: Humming for a Decade, NIH's Biowulf Cluster to Expand Storage Well Beyond 25 TB in 2009
Next week , the National Institute of Health's Biowulf Linux cluster will be at the center of a celebratory symposium in honor of its10th anniversary. (Fri, 30 Jan 2009 23:08:19 GMT)
Cancer, Cell Cycles, and Challenges
Over at Buried Treasure, Lars Juhl Jensen blogs about a recent attempt to use comparative computational approaches to mine gene expression data for cell cycle genes that might be implicated in cancer. (Fri, 30 Jan 2009 23:23:29 GMT)
Scientists analyze genome of a heat and drought resistant cereal plant
Berlin, Jan 31 : A team of scientists is analyzing the genes of sorghum, a heat and drought resistant cereal plant, which is the first plant of African origin whose genome has been sequenced. (Sat, 31 Jan 2009 09:20:18 GMT)
Potential Lung Cancer Drug Tested By Translational Genomics Research Insitute Affiliates
TGen Clinical Research Services (TCRS) at Scottsdale Healthcare and Mayo Clinic are testing a new drug that may offer broad potential to treat solid tumors. (Sat, 31 Jan 2009 11:05:59 GMT)
Pre-eclampsia may stem from misfolded proteins in urine
Washington, Jan 31: Scientists at Yale School of Medicine have found that the key to pre-eclampsia could be found in proteins that misfold and aggregate in the urine. (Sat, 31 Jan 2009 15:29:32 GMT)
Previous 1 2 3 4
